News BioXcel Therapeutics Receives Fast-Track Designation for BXCL701 in Prostate Cancer by Warren Seah February 12, 2024 by Warren Seah February 12, 2024 BioXcel Therapeutics, a leading biopharmaceutical company based in New Haven, Conn., announced today that its BXCL701… Read more